Bone profile: calcium, phosphate, ALP, PTH and vitamin D
How blood calcium, phosphate, alkaline phosphatase, PTH and 25-hydroxyvitamin D are read together: patterns from deficiency to CKD and cancer.
- A bone profile is read as a set, not as single numbers: calcium, phosphate, alkaline phosphatase (ALP), parathyroid hormone (PTH) and 25-hydroxyvitamin D (25-OHD) together describe bone turnover, parathyroid drive and vitamin D status.
- Always start with the calcium, adjusted for albumin, and with the laboratory's own reference range. Then look at whether PTH is appropriate for that calcium. [2]
- Ionised calcium is the biologically active form; most labs report total calcium, which has to be corrected when albumin is low.
- The most common patterns are primary hyperparathyroidism (high calcium, high or inappropriately normal PTH, low phosphate), vitamin D deficiency (low or normal calcium, high PTH, low 25-OHD) and the malignant pattern (high calcium, suppressed PTH).
- CKD mineral and bone disease, Paget disease and osteomalacia have their own recognisable shapes, usually involving ALP.
- Sample sheets and algorithms below are illustrative; they are not real patient data and the local laboratory interval always wins.
By the end of this page you should be able to:
- Choose between total, albumin-adjusted and ionised calcium, and correct total calcium for albumin.
- Explain how PTH, phosphate, ALP and 25-hydroxyvitamin D move together in the common disorders.
- Read a result sheet and state a one-line conclusion with the next step.
- State the vitamin D sufficiency cut-offs you are using and their source.
- List the NICE and KDIGO actions that depend on the level of albumin-adjusted calcium.
The bone profile is a small panel with a large amount of physiology behind it. Calcium is the signal, PTH is the messenger, phosphate is calcium's partner in bone and blood, ALP is a marker of bone formation, and 25-hydroxyvitamin D (25-OHD) is the storage form of vitamin D. Reading them together is more reliable than reading any of them alone, because each value changes the meaning of the others. A high calcium with a suppressed PTH points to non-parathyroid causes of hypercalcaemia, while the same calcium with a raised PTH points to the parathyroid gland. A raised ALP with low phosphate and high calcium behaves differently from a raised ALP with low 25-OHD.
This page treats the panel as an investigation, so it is organised around what the tests measure, the ranges used, the causes of high and low values, the patterns they form, and short sample result sheets to interpret. It is written for a reader meeting the panel for the first time; it assumes no prior knowledge of mineral metabolism.
Calcium. Most laboratories report total (serum) calcium. About 45 per cent of circulating calcium is bound to albumin, about 45 per cent is ionised and biologically active, and about 10 per cent is bound to small anions such as phosphate and citrate. [1] [2] The ionised (free) fraction is what the body actually senses, and it is what the parathyroid glands, bones and kidneys respond to. Total calcium is convenient and cheap but is an estimate of the ionised fraction, and it is unreliable whenever albumin or pH changes. [2]
Albumin-adjusted (corrected) calcium. Because so much calcium is albumin-bound, a low albumin makes total calcium look low even when the patient is normocalcaemic. The standard correction is:
corrected calcium (mg/dL) = measured total calcium + 0.8 x (4.0 - albumin in g/dL)
where albumin is in g/dL and total calcium in mg/dL. In SI terms total calcium falls by about 0.25 mmol/L for each 10 g/L fall in albumin below 40 g/L. [1] NICE calls this "albumin-adjusted serum calcium" and bases its thresholds (2.6 mmol/L or above, 2.85 mmol/L or above, 3.0 mmol/L or above) on it. [6] The correction is an approximation and is least reliable in critical illness, severe hypoalbuminaemia or abnormal pH; when in doubt measure ionised calcium directly. [2]
Ionised calcium. The direct measurement of the active fraction. It is necessary in critical care, after massive transfusion, in severe acid-base disturbance and in situations where albumin is unreliable. [1] It requires an anaerobic sample handled carefully. NICE states that ionised calcium should not be measured when testing for primary hyperparathyroidism; use albumin-adjusted serum calcium instead. [6]
Phosphate. Phosphate is calcium's partner in bone mineral (hydroxyapatite) and a key intracellular anion. Renal excretion is the main regulator, with PTH, vitamin D and calcitonin acting on it alongside calcium. [6] [8] Because PTH inhibits renal phosphate reabsorption, phosphate falls as PTH rises.
Alkaline phosphatase (ALP). ALP is a membrane-bound enzyme. More than 80 per cent of serum ALP comes from liver and bone, with smaller contributions from intestine, placenta, kidney and (in pregnancy) placenta. [7] An isolated rise therefore needs a hepatic source to be excluded (for example with GGT) before it is attributed to bone. [1] In children, adolescents and pregnancy, ALP is physiologically higher because of bone growth or the placental isoenzyme. [12]
Parathyroid hormone (PTH). PTH is secreted by the parathyroid glands in response to a low ionised calcium, detected by the calcium-sensing receptor. It raises serum calcium by stimulating osteoclastic bone resorption, renal calcium reabsorption and calcitriol synthesis (which in turn increases intestinal calcium absorption), and it lowers serum phosphate by inhibiting renal phosphate reabsorption. [3] [9] PTH is the messenger whose appropriateness you judge against the calcium.
25-hydroxyvitamin D (25-OHD). This is the storage (circulating) form, the best marker of vitamin D status. It is hydroxylated in the liver and then converted in the kidney to the active form, calcitriol (1,25-dihydroxyvitamin D), under the control of PTH and FGF23. [4] [9] Assays differ, which is why guideline thresholds come from defined methods and should not be over-interpreted.
Ranges are assay-, age-, sex- and population-specific, and for several analytes they change with posture, time of day, fasting and pregnancy. The local laboratory interval printed on the result is authoritative. Where laboratory and textbook disagree, the laboratory wins. [1] [2]
| Analyte | Conventional units | SI units | Source and condition |
|---|---|---|---|
| Total calcium | 8.5-10.5 mg/dL (one system 8.9-10.1 mg/dL) | 2.12-2.62 mmol/L | StatPearls hypocalcaemia; StatPearls hypercalcaemia (adult, laboratory-dependent) [1] [2] [6] |
| Ionised (free) calcium | 4.65-5.25 mg/dL | 1.16-1.31 mmol/L | StatPearls hypocalcaemia [1] |
| Albumin, for correction | (conventional as required by formula) | 40 g/L reference value used in the correction formula | StatPearls hypocalcaemia: total calcium falls about 0.25 mmol/L per 10 g/L fall below 40 g/L [1] |
| Phosphate | (timing, fasting and renal function matter) | method- and age-specific; interpret against the laboratory interval, and remember that renal handling governs it | StatPearls electrolytes; MedlinePlus phosphate page [6] |
| Alkaline phosphatase | U/L | U/L or micromol/L | Age, sex and method dependent; liver plus bone fractions dominate; GGT separates hepatic from bone source [7] |
| Intact PTH | (method-specific) | method-specific | No single published universal interval; judge against albumin-adjusted calcium on the same sample [6] [9] |
| 25-hydroxyvitamin D | (ng/mL) | (nmol/L) | StatPearls (quoting 2019 Endocrine Society thresholds): sufficiency over 30 ng/mL (50 nmol/L); insufficiency 12-30 ng/mL (30-77 nmol/L); deficiency under 12 ng/mL (30 nmol/L) [4] |
A correction of total calcium for albumin is only an estimate. Ionised calcium is required in acidosis, alkalosis, massive transfusion, severe hypoalbuminaemia and critical illness. [2] The CaSR set point means that a "normal" calcium value is itself variable between people, which contributes to the overlap between health and disease. [3]
Causes are listed by the analyte most affected, but remember that a change in one value almost always changes another. PAUSE: high calcium with a normal or high PTH is not normal, because PTH should be suppressed by calcium. [3] [6]
| Analyte | High (raised) | Low (reduced) |
|---|---|---|
| Calcium (albumin-adjusted or ionised) | Primary hyperparathyroidism; malignancy (humoral hypercalcaemia of malignancy via PTHrP, osteolytic metastases, calcitriol-producing tumours); granulomatous disease (sarcoidosis, tuberculosis); thiazides or lithium; milk-alkali; immobilisation; familial hypocalciuric hypercalcaemia [2] [3] [6] [9] | Vitamin D deficiency or defective metabolism; hypoparathyroidism; CKD; malabsorption; hungry bone; hyperphosphataemia; acute pancreatitis; citrate transfusion; hypomagnesaemia [1] [6] [8] |
| Phosphate | CKD or reduced GFR; hypoparathyroidism; acromegaly; tumour lysis or cell breakdown; phosphate supplementation; high vitamin D intake | Primary hyperparathyroidism; vitamin D deficiency; Fanconi syndrome or renal phosphate wasting; malnutrition or malabsorption; refeeding with carbohydrate; chronic diarrhoea [6] [8] |
| ALP | Paget disease of bone; osteomalacia and rickets (high bone formation); primary hyperparathyroidism; healing fractures; growth in children; pregnancy (placental); liver disease, cholestasis or biliary obstruction; metastatic bone disease; Hodgkin lymphoma | Hypophosphatasia; zinc deficiency; protein or severe malnutrition; hypothyroidism; wilson disease; pernicious anaemia [7] [12] |
| PTH | Secondary hyperparathyroidism (vitamin D deficiency, CKD, calcium malabsorption, malnutrition); primary and tertiary hyperparathyroidism; lithium or thiazides; hungry bone | Hypoparathyroidism (surgical, autoimmune, genetic); hypomagnesaemia (functional); hypercalcaemia (suppression in malignancy or granulomatous disease) [3] [6] [9] |
| 25-hydroxyvitamin D | High intake, supplementation or fortification; granulomatous overproduction turning 25-OHD into calcitriol is not a high 25-OHD state (it is normal 25-OHD with high calcitriol) | Lack of sun exposure; dark skin; malabsorption; chronic liver or kidney disease; obesity; age; dark skin underrepresented in reference populations [4] [10] [12] |
The single most useful question in this panel is: is the PTH appropriate for the calcium? In primary hyperparathyroidism calcium is high and PTH is elevated or inappropriately normal (not suppressed). In hypercalcaemia of malignancy, granulomatous disease, milk-alkali and thyrotoxicosis, calcium is high and PTH is suppressed. [3] [9]
Reading a bone profile
- Calcium (albumin-adjusted)Classify as low, normal or high against the laboratory interval
- PTH on the same sampleAsk whether PTH is appropriate (suppressed when calcium is high, raised when calcium is low)
- Question: Adjusted calcium?
High (>=2.6 mmol/L)
- Question: PTH?
High or inappropriately normal
- Primary hyperparathyroidism (commonest outpatient cause)Confirm with repeat adjusted calcium and PTH; exclude familial hypocalciuric hypercalcaemia with urine calcium
Suppressed
- Non-parathyroid hypercalcaemiaMalignancy, granulomatous disease, drugs, milk-alkali, immobilisation, thyrotoxicosis
Normal
- Normocalcaemic primary hyperparathyroidismRaised PTH with normal adjusted calcium, after secondary causes (vitamin D deficiency, CKD, malabsorption) are excluded
- Familial hypocalciuric hypercalcaemiaMild lifelong calcium from about 2.5-2.6 mmol/L with low urine calcium
Low
- Question: PTH?
High (appropriate)
- Secondary hyperparathyroidismVitamin D deficiency, CKD, calcium malabsorption, low magnesium
Low or inappropriately normal
- HypoparathyroidismSurgical, autoimmune, genetic; or functional hypoparathyroidism in hypomagnesaemia
- Phosphate and ALPPhosphate falls as PTH rises; ALP marks bone turnover (Paget, osteomalacia, metastases, fracture healing, growth)
- 25-OHDLow 25-OHD supports vitamin D deficiency, osteomalacia or secondary hyperparathyroidism; sufficiency defined as above 30 ng/mL (50 nmol/L) on 2019 Endocrine Society thresholds
The named combinations (the "patterns" that exam questions test):
- Primary hyperparathyroidism = high albumin-adjusted calcium, high or inappropriately normal PTH, low or low-normal phosphate, often a raised ALP and low or low-normal 25-OHD. [3] [9] The most common cause is a single benign parathyroid adenoma. [3]
- Hypercalcaemia of malignancy = high calcium, suppressed (low) PTH, commoner in inpatients, often more severe than PHPT hypercalcaemia. [9]
- Familial hypocalciuric hypercalcaemia (FHH) = lifelong mild hypercalcaemia (around 2.5-2.7 mmol/L) with an inappropriately normal PTH and a low urine calcium to creatinine clearance ratio (under 0.01), not 0.02 or more as in PHPT. [9] [6]
- Vitamin D deficiency = 25-OHD under 12 ng/mL (30 nmol/L) on the 2019 Endocrine Society thresholds quoted in StatPearls; calcium low or normal, phosphate low or low-normal, ALP raised (osteomalacia), PTH raised (secondary hyperparathyroidism). [4]
- CKD mineral and bone disease = low or falling calcium in late disease, high phosphate (reduced GFR), high PTH (secondary hyperparathyroidism), often raised ALP and low 25-OHD. [8]
- Paget disease of bone = normal calcium and phosphate, markedly raised bone ALP, PTH normal; the high ALP is the clue, and GGT is normal if liver is the source. [7] [12]
- Osteomalacia = low or normal calcium, low phosphate, high ALP, high PTH, low 25-OHD. [4] [5]
- Hypoparathyroidism = low calcium, high phosphate, low or inappropriately normal PTH (the mirror image of PHPT). [1] [6]
- Milk-alkali syndrome / supplements = high calcium, low or normal PTH, normal phosphate, alkalosis. [2]
- Hypomagnesaemia = functional hypoparathyroidism: low calcium, high phosphate, low PTH that corrects when magnesium is replaced. [1]
Kidney and skeletal complications move the decision, not the biochemical numbers alone. NICE refers people with confirmed PHPT to surgery when they have symptoms of hypercalcaemia (thirst, polyuria, constipation), end-organ disease (renal stones, fragility fractures or osteoporosis) or an albumin-adjusted calcium of 2.85 mmol/L or above. [6]
Every value below is original and invented for teaching; these are not real patient results. The ranges, thresholds and rules in the interpretation are claims from the cited sources.
Sheet 1: normal adult, no disease
| Test | Result | Unit | Reference range | Flag |
|---|---|---|---|---|
| Adjusted calcium | 2.42 | mmol/L | 2.12-2.62 | Normal |
| Phosphate | 1.10 | mmol/L | laboratory range | Normal |
| ALP | 88 | U/L | laboratory range | Normal |
| PTH | 3.4 | pmol/L | method-specific | Normal |
| 25-OHD | 52 | nmol/L | over 50 (for sufficiency) | Normal |
Interpretation:
- Adjusted calcium is 2.42 mmol/L, which lies within the 2.12-2.62 mmol/L interval and is not 2.6 or above, so there is no hypercalcaemia. [1] [6]
- PTH is 3.4 pmol/L and stated as normal for the method.
- A normal calcium with a normal PTH and a normal 25-OHD (over 30 ng/mL / 50 nmol/L on the 2019 Endocrine Society thresholds quoted by StatPearls) excludes the common parathyroid and vitamin D problems. [4]
- Conclusion: no biochemical abnormality of mineral metabolism; nothing further is required beyond routine care.
Sheet 2: primary hyperparathyroidism
| Test | Result | Unit | Reference range | Flag |
|---|---|---|---|---|
| Adjusted calcium | 2.91 | mmol/L | 2.12-2.62 | High |
| Phosphate | 0.72 | mmol/L | laboratory range | Low |
| ALP | 96 | U/L | laboratory range | Normal or high-normal |
| PTH | 9.6 | pmol/L | method-specific | High |
| 25-OHD | 34 | nmol/L | under 50 | Low-insufficient |
Interpretation:
- Adjusted calcium 2.91 mmol/L is 2.6 or above and therefore hypercalcaemia, and 2.85 or above, which meets the NICE surgical-referral calcium threshold when combined with the clinical assessment. [6]
- PTH 9.6 pmol/L is not suppressed; it is elevated, so in the presence of a high calcium this is an inappropriate PTH. [3] [6]
- Phosphate is low, the expected phosphaturic effect of PTH. [3] [9]
- 25-OHD 34 nmol/L is under 50 nmol/L, so vitamin D repletion is advised before any surgical decision. NICE recommends measuring vitamin D in probable PHPT and offering supplementation. [6]
- Conclusion: primary hyperparathyroidism is the most likely diagnosis; repeat adjusted calcium and PTH on at least two occasions 2 weeks apart, check urine calcium to exclude FHH, measure 25-OHD, renal tract ultrasound and DXA, and decide referral. [6] [9]
Sheet 3: malignant hypercalcaemia
| Test | Result | Unit | Reference range | Flag |
|---|---|---|---|---|
| Adjusted calcium | 3.24 | mmol/L | 2.12-2.62 | High |
| Phosphate | 1.35 | mmol/L | laboratory range | Normal |
| ALP | 180 | U/L | laboratory range | High |
| PTH | 0.8 | pmol/L | method-specific | Suppressed |
| 25-OHD | 41 | nmol/L | under 50 | Low-insufficient |
Interpretation:
- Adjusted calcium 3.24 mmol/L is severe hypercalcaemia. Phosphate is normal rather than low. [2] [3]
- PTH 0.8 pmol/L is suppressed, below the midpoint of the reference range, so the parathyroid glands are not the driver; this is non-parathyroid hypercalcaemia. [6] [9]
- The high ALP with normal phosphate and suppressed PTH fits malignant or osteolytic disease, although the pattern needs radiology and a cancer history; ALP alone cannot localise its source without GGT or isoenzymes. [7]
- Conclusion: the pattern is of malignancy-related or other non-PTH hypercalcaemia; investigate for cancer and granulomatous disease, treat the calcium urgently, and do not refer for parathyroid surgery.
- Low albumin. A total calcium at the lower end of the range may simply be hypoalbuminaemia. Correct it, or measure ionised calcium. [1] [2]
- Acid-base. Acidosis increases ionised calcium at the expense of protein-bound calcium; alkalosis does the reverse. A normal total calcium in severe alkalosis can hide a symptomatic low ionised calcium. [2]
- Ionised calcium in PHPT. NICE says do not measure ionised calcium when testing for primary hyperparathyroidism; use albumin-adjusted serum calcium. [6]
- ALP source. An ALP rise is not "bone" until a hepatic cause is excluded (for example with GGT or an isoenzyme); liver and bone together account for over 80 per cent of serum ALP. [7]
- Normal calcium does not exclude PHPT. Normocalcaemic PHPT exists and is a diagnosis of exclusion after secondary hyperparathyroidism (vitamin D deficiency, CKD, malabsorption) has been ruled out. [9]
- Vitamin D thresholds. The 12, 30 and (using the Endocrine Society values quoted by StatPearls) 30 ng/mL numbers here are the 2019 Endocrine Society cut-offs; the 2024 Endocrine Society guideline did not support routine 25-OHD testing in asymptomatic adults and did not define an optimal disease-prevention target. [4] [11] [9]
- ** assay-specific intervals.** Only cholesterol, creatinine and HbA1c are internationally harmonised; PTH, vitamin D and ALP in particular are method-specific. [2]
- Pregnancy. ALP rises because of the placental isoenzyme and 25-OHD interpretation changes; use pregnancy-adjusted intervals. [12]
- Ionised (free) calcium is the physiologically active fraction; total and albumin-adjusted calcium are its surrogates. [1] [2]
- Correct total calcium for albumin: subtract about 0.25 mmol/L per 10 g/L of albumin below 40 g/L. [1]
- NICE defines hypercalcaemia as an albumin-adjusted serum calcium of 2.6 mmol/L or above. [6]
- Do not measure ionised calcium for suspected primary hyperparathyroidism; use albumin-adjusted calcium. [6]
- Primary hyperparathyroidism is the commonest outpatient cause of hypercalcaemia and is diagnosed biochemically by high (or inappropriately normal) PTH with hypercalcaemia. [3] [6]
- Hypercalcaemia of malignancy shows suppressed PTH and is the key differential. [9]
- PTH raises calcium and lowers phosphate, so the calcium-phosphate direction is informative. [3] [9]
- ALP comes mainly from liver and bone; exclude liver before attributing a rise to bone. [7]
- Paget disease and osteomalacia are classic causes of markedly raised bone ALP. [7] [5]
- Vitamin D deficiency (25-OHD under 12 ng/mL / 30 nmol/L on 2019 Endocrine Society thresholds) causes secondary hyperparathyroidism, hypophosphataemia and osteomalacia. [4]
- CKD mineral and bone disease produces high phosphate, high PTH and often low 25-OHD. [8]
- NICE refers PHPT to surgery for symptoms, end-organ disease or albumin-adjusted calcium 2.85 mmol/L or above; offers cinacalcet (not in pregnancy) at 2.85 mmol/L with symptoms or 3.0 mmol/L without. [6]
- The 2024 Endocrine Society guideline advised against routine 25-OHD testing in asymptomatic people in the absence of established indications. [11]
- NICE PH56 targets supplement access for infants and children under 4, pregnant and breastfeeding women, people over 65 and those with low sun exposure or dark skin. [12]
Answer each one in your head first, then open the answer.
A 62-year-old woman has an adjusted serum calcium of 2.88 mmol/L, PTH 11.2 pmol/L, phosphate 0.68 mmol/L and 25-OHD 28 nmol/L. What is the diagnosis and the next steps?
Show answerHide answer
Primary hyperparathyroidism: a high calcium with an inappropriately raised PTH and a low phosphate. Next, repeat adjusted calcium and PTH 2 weeks apart; exclude familial hypocalciuric hypercalcaemia with urine calcium; replete vitamin D (25-OHD under 50 nmol/L); check renal tract ultrasound, eGFR and DXA; decide referral, because the calcium of 2.88 mmol/L meets the NICE 2.85 mmol/L surgical-referral threshold. [6] [9]
A 70-year-old man with known lung cancer has calcium 3.18 mmol/L (adjusted), PTH 0.6 pmol/L, phosphate 1.4 mmol/L and ALP 210 U/L. Interpret the sheet and state the likely cause.
Show answerHide answer
Severe hypercalcaemia with suppressed PTH is the malignant (non-parathyroid) pattern. Normal phosphate and a high ALP fit osteolytic or metastatic disease, but ALP cannot localise its own source without GGT or isoenzymes. The conclusion is malignancy-related hypercalcaemia: investigate urgently and treat the calcium, not parathyroid surgery. [2] [7] [9]
A 55-year-old woman has adjusted calcium 2.25 mmol/L, PTH 8.5 pmol/L, phosphate 0.78 mmol/L, ALP 140 U/L and 25-OHD 18 nmol/L. What does the pattern suggest?
Show answerHide answer
Why must total calcium be corrected for albumin, and when is the correction unreliable?
Show answerHide answer
About 45 per cent of circulating calcium is albumin-bound, so a low albumin lowers total calcium even when ionised calcium is normal. Correction subtracts roughly 0.25 mmol/L per 10 g/L below 40 g/L. It is unreliable in severe acid-base disturbance, critical illness, massive transfusion and severe hypoalbuminaemia; ionised calcium should be measured directly then. [1] [2]
A child has ALP 420 U/L and the adult range is quoted as 40-129 U/L in men. Is this necessarily abnormal?
Related topics (plain text, linked from the registry as they are published): hypercalcaemia; hypocalcaemia; hyperparathyroidism; CKD mineral and bone disease; osteomalacia and rickets; Paget disease of bone; vitamin D deficiency; kidney failure and urea; osteoporosis; common laboratory reference values.
- Anastasopoulou C, Goyal A. Hypocalcemia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2026 Jun 8. Accessed .
- Sadiq NM, Anastasopoulou C, Patel G, Badireddy M. Hypercalcemia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2024 May 7. Accessed .
- Helbing A, Leslie SW, Levine SN. Primary Hyperparathyroidism. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2026 Jan 31. Accessed .
- Kaur J, Khare S, Givler A. Vitamin D Deficiency. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2025 Feb 15. Accessed .
- Zimmerman L, Anastasopoulou C, McKeon B. Osteomalacia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2024 Sep 2. Accessed .
- Shrimanker I, Bhattarai S. Electrolytes. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2023 Jul 24. Accessed .
- Lowe D, Sanvictores T, Zubair M, John S. Serum Alkaline Phosphatase: Clinical and Laboratory Perspectives. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2026 Mar 23. Accessed .
- National Institute for Health and Care Excellence. Hyperparathyroidism (primary): diagnosis, assessment and initial management (NG132). NICE guideline NG132, published 23 May 2019. Accessed .
- Kochman M. Primary hyperparathyroidism: clinical manifestations, diagnosis and evaluation according to the Fifth International Workshop guidelines. Reumatologia 2023;61(4):256-263. doi:10.5114/reum/170705. Accessed .
- Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO CKD-MBD Guideline Update. Kidney Int 2017;92(1):26-36. doi:10.1016/j.kint.2017.04.006. Accessed .
- Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2024;109(8):1907-1947. doi:10.1210/clinem/dgae290. Accessed .
- National Institute for Health and Care Excellence. Vitamin D: supplement use in specific population groups (PH56). NICE public health guideline PH56, published 26 Nov 2014, last updated 30 Aug 2017. Accessed .
Educational content for medical students and doctors. It is not a substitute for clinical judgement or local guidelines.